Beacon Capital Management LLC (Tennessee)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-14
Closed -$2.11K – 1096
2025
Q1
$2.11K Hold
14
– – ﹤0.01% 937
2024
Q4
$2.58K Hold
14
– – ﹤0.01% 844
2024
Q3
$2.76K Buy
+14
New +$2.91K ﹤0.01% 924

Other funds holding CRL

Beacon Capital Management LLC (Tennessee)'s CRL Position: Q2 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 14 shares — an estimated $2.11K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in CRL in Q3 2024 and held it in 3 quarters. The position peaked at $2.76K in Q3 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 14 Charles River Laboratories shares in Q2 2025, an estimated $2.11K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Charles River Laboratories in Q3 2024 and held it in 3 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Charles River Laboratories position peaked at $2.76K in Q3 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2025, filed 17 Jul 2025.